Dynavax Reports Fourth Quarter and Year End 2015 Financial Results

Go back to Dynavax Reports Fourth Quarter and Year End 2015 Financial Results

Dynavax (DVAX) Tops Q3 EPS by 5c

March 8, 2016 7:02 AM EST

Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $685 thousand versus the consensus estimate of $1.15 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

... More